vs
Side-by-side financial comparison of DuPont (DD) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
DuPont is the larger business by last-quarter revenue ($1.7B vs $1.5B, roughly 1.1× BeOne Medicines Ltd.). DuPont runs the higher net margin — 9.8% vs 4.4%, a 5.3% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 4.0%). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs -27.2%).
DuPont de Nemours, Inc., commonly shortened to DuPont, is an American multinational chemical company first formed in 1802 by French-American chemist and industrialist Éleuthère Irénée du Pont de Nemours. The company played a major role in the development of the U.S. state of Delaware and first arose as a major supplier of gunpowder.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
DD vs ONC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.7B | $1.5B |
| Net Profit | $164.0M | $66.5M |
| Gross Margin | 35.8% | 90.5% |
| Operating Margin | — | 12.4% |
| Net Margin | 9.8% | 4.4% |
| Revenue YoY | 4.0% | 32.8% |
| Net Profit YoY | — | 143.8% |
| EPS (diluted) | $0.36 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.7B | — | ||
| Q4 25 | $-2.5B | $1.5B | ||
| Q3 25 | $3.1B | $1.4B | ||
| Q2 25 | $3.3B | $1.3B | ||
| Q1 25 | $3.1B | $1.1B | ||
| Q4 24 | $3.1B | $1.1B | ||
| Q3 24 | $3.2B | $1.0B | ||
| Q2 24 | $3.2B | $929.2M |
| Q1 26 | $164.0M | — | ||
| Q4 25 | $-126.0M | $66.5M | ||
| Q3 25 | $-123.0M | $124.8M | ||
| Q2 25 | $59.0M | $94.3M | ||
| Q1 25 | $-589.0M | $1.3M | ||
| Q4 24 | $-118.0M | $-151.9M | ||
| Q3 24 | $454.0M | $-121.3M | ||
| Q2 24 | $178.0M | $-120.4M |
| Q1 26 | 35.8% | — | ||
| Q4 25 | — | 90.5% | ||
| Q3 25 | 38.9% | 86.1% | ||
| Q2 25 | 37.3% | 87.5% | ||
| Q1 25 | 37.4% | 85.2% | ||
| Q4 24 | 36.4% | 85.8% | ||
| Q3 24 | 37.4% | 83.0% | ||
| Q2 24 | 37.1% | 85.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 12.4% | ||
| Q3 25 | 10.6% | 11.5% | ||
| Q2 25 | 9.4% | 6.7% | ||
| Q1 25 | -14.0% | 1.0% | ||
| Q4 24 | 1.4% | -7.0% | ||
| Q3 24 | 18.4% | -12.0% | ||
| Q2 24 | 9.3% | -11.5% |
| Q1 26 | 9.8% | — | ||
| Q4 25 | 4.9% | 4.4% | ||
| Q3 25 | -4.0% | 8.8% | ||
| Q2 25 | 1.8% | 7.2% | ||
| Q1 25 | -19.2% | 0.1% | ||
| Q4 24 | -3.8% | -13.5% | ||
| Q3 24 | 14.2% | -12.1% | ||
| Q2 24 | 5.6% | -13.0% |
| Q1 26 | $0.36 | — | ||
| Q4 25 | $-0.30 | $0.05 | ||
| Q3 25 | $-0.29 | $0.08 | ||
| Q2 25 | $0.14 | $0.06 | ||
| Q1 25 | $-1.41 | $0.00 | ||
| Q4 24 | $-0.28 | $-0.10 | ||
| Q3 24 | $1.08 | $-0.09 | ||
| Q2 24 | $0.42 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $710.0M | $4.5B |
| Total DebtLower is stronger | $3.2B | $836.4M |
| Stockholders' EquityBook value | $14.2B | $4.4B |
| Total Assets | $21.4B | $8.2B |
| Debt / EquityLower = less leverage | 0.22× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $710.0M | — | ||
| Q4 25 | $715.0M | $4.5B | ||
| Q3 25 | $2.0B | $4.0B | ||
| Q2 25 | $1.8B | $2.8B | ||
| Q1 25 | $1.8B | $2.5B | ||
| Q4 24 | $1.9B | $2.6B | ||
| Q3 24 | $1.6B | $2.7B | ||
| Q2 24 | $1.5B | $2.6B |
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.1B | $836.4M | ||
| Q3 25 | $7.0B | — | ||
| Q2 25 | $5.3B | — | ||
| Q1 25 | $5.3B | — | ||
| Q4 24 | $5.3B | — | ||
| Q3 24 | $7.2B | — | ||
| Q2 24 | $7.2B | — |
| Q1 26 | $14.2B | — | ||
| Q4 25 | $13.9B | $4.4B | ||
| Q3 25 | $22.9B | $4.1B | ||
| Q2 25 | $23.1B | $3.8B | ||
| Q1 25 | $22.8B | $3.5B | ||
| Q4 24 | $23.4B | $3.3B | ||
| Q3 24 | $24.2B | $3.4B | ||
| Q2 24 | $23.3B | $3.4B |
| Q1 26 | $21.4B | — | ||
| Q4 25 | $21.6B | $8.2B | ||
| Q3 25 | $38.0B | $7.6B | ||
| Q2 25 | $36.6B | $6.3B | ||
| Q1 25 | $36.0B | $5.8B | ||
| Q4 24 | $36.6B | $5.9B | ||
| Q3 24 | $37.5B | $5.8B | ||
| Q2 24 | $36.6B | $5.7B |
| Q1 26 | 0.22× | — | ||
| Q4 25 | 0.23× | 0.19× | ||
| Q3 25 | 0.31× | — | ||
| Q2 25 | 0.23× | — | ||
| Q1 25 | 0.23× | — | ||
| Q4 24 | 0.23× | — | ||
| Q3 24 | 0.30× | — | ||
| Q2 24 | 0.31× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $417.3M |
| Free Cash FlowOCF − Capex | — | $379.8M |
| FCF MarginFCF / Revenue | — | 25.4% |
| Capex IntensityCapex / Revenue | 6.1% | 2.5% |
| Cash ConversionOCF / Net Profit | — | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-700.0M | $417.3M | ||
| Q3 25 | $497.0M | $402.6M | ||
| Q2 25 | $381.0M | $263.6M | ||
| Q1 25 | $382.0M | $44.1M | ||
| Q4 24 | $564.0M | $75.2M | ||
| Q3 24 | $737.0M | $188.4M | ||
| Q2 24 | $527.0M | $-95.6M |
| Q1 26 | — | — | ||
| Q4 25 | $-850.0M | $379.8M | ||
| Q3 25 | $379.0M | $354.5M | ||
| Q2 25 | $265.0M | $219.8M | ||
| Q1 25 | $133.0M | $-12.3M | ||
| Q4 24 | $403.0M | $-17.3M | ||
| Q3 24 | $628.0M | $54.7M | ||
| Q2 24 | $425.0M | $-205.5M |
| Q1 26 | — | — | ||
| Q4 25 | 33.4% | 25.4% | ||
| Q3 25 | 12.3% | 25.1% | ||
| Q2 25 | 8.1% | 16.7% | ||
| Q1 25 | 4.3% | -1.1% | ||
| Q4 24 | 13.0% | -1.5% | ||
| Q3 24 | 19.7% | 5.5% | ||
| Q2 24 | 13.4% | -22.1% |
| Q1 26 | 6.1% | — | ||
| Q4 25 | -5.9% | 2.5% | ||
| Q3 25 | 3.8% | 3.4% | ||
| Q2 25 | 3.6% | 3.3% | ||
| Q1 25 | 8.1% | 5.0% | ||
| Q4 24 | 5.2% | 8.2% | ||
| Q3 24 | 3.4% | 13.3% | ||
| Q2 24 | 3.2% | 11.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 6.28× | ||
| Q3 25 | — | 3.22× | ||
| Q2 25 | 6.46× | 2.79× | ||
| Q1 25 | — | 34.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.62× | — | ||
| Q2 24 | 2.96× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
